Despite Brexit, EMA's procedures and work streams continue as usual

As European Union member states vie to get re-location of the  European Medicines Agency to their country following the UK referendum vote to leave the EU, Spain being the latest to pitch its case, the EMA acknowledges the outcome and says it is now up to the UK government to decide how to act.

The EMA underlined that its procedures and work streams are not affected by the outcome of the referendum. The Agency will continue its operations as usual, in accordance with the timelines set by its rules and regulations.

No member state has ever decided to leave the EU, so there is no precedent for this situation. The implications for the seat and operations of EMA depend on the future relationship between the UK and the EU. “This is unknown at present and therefore we will not engage in any speculations,” it states.